PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|7|752-767

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.7, 2013-06, pp. : 752-767

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donepezil: potential neuroprotective and disease-modifying effects

By Jacobson Sandra A   Sabbagh Marwan N  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 10, 2008-10 ,pp. : 1363-1369

Informa Healthcare

Access to resources Recommend Favorite

Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease

By Beher Dirk   Graham Samuel L  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1385-1409

Informa Healthcare

Access to resources Recommend Favorite

Chinese Herbs as Immunomodulators and Potential Disease-Modifying Antirheumatic Drugs in Autoimmune Disorders

By  

Current Drug Metabolism, Vol. 5, Iss. 2, 2004-04 ,pp. : 181-192

Bentham Science Publishers

Access to resources Recommend Favorite

Impact and Therapeutic Potential of PPARs in Alzheimer's Disease

By  

Current Neuropharmacology, Vol. 9, Iss. 4, 2011-12 ,pp. : 643-650

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease: A Review of Symptomatic and Potential Disease-Modifying Effects

By Schapira Anthony H.V.  

CNS Drugs, Vol. 25, Iss. 12, 2011-12 ,pp. : 1061-1071

Adis International

Access to resources Recommend Favorite